International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997

Depression and Anxiety

Volumn 9, Issue 3, 1999, Pages 107-116

  Uhlenhuth, E H ^a   Balter, Mitchell B ^b,c   Ban, Thomas A ^d   Yang, Kenneth ^e  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b Public Health Research Center Inc   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Systems Concept Inc   (United States)

Author keywords

Antidepressants; Anxiety disorders; Benzodiazepines; Psychotherapy

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGORAPHOBIA; ANXIETY NEUROSIS; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; DRUG CHOICE; HUMAN; INTERNATIONAL COOPERATION; MEDICAL EXPERT; OBSESSION; PANIC; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; SOCIAL PHOBIA; TREATMENT PLANNING;

ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; BENZODIAZEPINES; DRUG THERAPY, COMBINATION; HEALTH CARE SURVEYS; HUMANS; LONGITUDINAL STUDIES; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRY;

EID: 0033044469     PISSN: 10914269     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T     Document Type: Article

References (25)

1. American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, D.C.: American Psychiatric Association.
2. Aronson TA. 1987. A naturalistic study of imipramine in panic disorder and agoraphobia. Am J Psychiatry 144:1014-1019.
3. Balter MB, Ban TA, Uhlenhuth EH. 1993. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: I. Current concerns. Human Psychopharmacol 8:253-261.
4. Barlow DH, Lehman CL. 1996. Advances in the psychosocial treatment of anxiety disorders: implications for national health care. Arch Gen Psychiatry 53:727-735.
5. th Annual Meeting of the New Clinical Drug Evaluation Unit Program, Boca Raton, FL, June 10-13.
6. Faccoro BC, Gomezhernandez R. 1997. Treatment resistant obsessive-compulsive disorder: an update. Actas Luso-Espanolas de Neurologia, Psiquiatria y Ciences Afines 25:61-69.
7. Gorman JM. 1997. The use of newer antidepressants for panic disorder. J Clin Psychiatry 58(Suppl 14):54-58.
8. Gorman J, Shear K. 1998. Practice guideline for the treatment of patients with panic disorder. Am J Psychiatry 155(5, Suppl).
9. Keck PE Jr, McElroy SL. 1997. New uses for antidepressants: social phobia. J Clin Psychiatry 58(Suppl 14):32-36.
10. Klein DF. 1993. Clinical psychopharmacologic practice: the need for developing a research base. Arch Gen Psychiatry 50(6):491-494.
11. Leonard KL. 1997. New developments in the treatment of obsessive-compulsive disorder. J Clin Psychiatry 58 (Suppl 14):39-45.
12. Lopes CS, Rodrigues LC, Sichieri R. 1996. The lack of selection bias in a snowball sampled case-control study on drug abuse. Int J Epidemiol 25:1267-1270.
13. Lydiard RB, Brawman-Mintzner O, Ballenger JC. 1996. Recent developments in the psychopharmacology of anxiety disorders. J Consult Psychology 64:660-668.
14. Mavissakalian MR, Perel JM. 1995. Imipramine treatment of panic disorder with agoraphobia: dose ranging and plasma level-response relationships. Am J Psychiatry 152:673-682.
15. Michielutte R, Beal P. 1990. Identification of community leadership in the development of public health education programs. J Commun Health 15:59-68.
16. Nutt D. 1997. Management of patients with depression associated with anxiety symptoms. J Clin Psychiatry 58 (Suppl 8):11-16.
17. Pohl R, Yerevgani VK, Balon R, Lycaki H. 1988. The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 49:100-104.
18. Rosenbaum JF. 1997. Treatment-resistant panic disorder. J Clin Psychiatry 58 (Suppl 2):61-65.
19. Sheehan DV, Harnett-Sheehan K. 1996. The role of SSRIs in panic disorder. J Clin Psychiatry 57 (Suppl 10):51-58.
20. Spiegel DA, Bruce TJ. 1997. Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials. Am J Psychiatry 154:773-781.
21. Thompson SK. 1997. Adaptive sampling in behavioral surveys. National Institute on Drug Abuse: Research Monograph Series 167:296-319.
22. Uhlenhuth EH, Balter MB, Ban TA, Yang K. 1995a. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. J Affect Disord 35:153-162.
23. Uhlenhuth EH, Balter MB, Ban TA, Yang K. 1995b. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disorders. Psychopharmacol Bull 31:289-296.
24. Uhlenhuth EH, Matuzas W, Glass RM, Easton C. 1989. Response of panic disorder to fixed doses of alprazolam or imipramine. J Affect Disord 17:261-270.
25. Van Meter KM. 1990. Methodological and design issues: Techniques for assessing the representativeness of snowball samples. National Institute on Drug Abuse: Research Monograph Series 98:31-43.